120 related articles for article (PubMed ID: 15308763)
1. Modulation of cellular cholesterol alters P-glycoprotein activity in multidrug-resistant cells.
Troost J; Lindenmaier H; Haefeli WE; Weiss J
Mol Pharmacol; 2004 Nov; 66(5):1332-9. PubMed ID: 15308763
[TBL] [Abstract][Full Text] [Related]
2. Role of P-glycoprotein in accumulation and cytotoxicity of amrubicin and amrubicinol in MDR1 gene-transfected LLC-PK1 cells and human A549 lung adenocarcinoma cells.
Hira A; Watanabe H; Maeda Y; Yokoo K; Sanematsu E; Fujii J; Sasaki J; Hamada A; Saito H
Biochem Pharmacol; 2008 Feb; 75(4):973-80. PubMed ID: 18054347
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance gene G1199A polymorphism alters efflux transport activity of P-glycoprotein.
Woodahl EL; Yang Z; Bui T; Shen DD; Ho RJ
J Pharmacol Exp Ther; 2004 Sep; 310(3):1199-207. PubMed ID: 15100388
[TBL] [Abstract][Full Text] [Related]
4. Multidrug-resistant cancer cells contain two populations of P-glycoprotein with differently stimulated P-gp ATPase activities: evidence from atomic force microscopy and biochemical analysis.
Barakat S; Gayet L; Dayan G; Labialle S; Lazar A; Oleinikov V; Coleman AW; Baggetto LG
Biochem J; 2005 Jun; 388(Pt 2):563-71. PubMed ID: 15693753
[TBL] [Abstract][Full Text] [Related]
5. Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells.
Gayet L; Dayan G; Barakat S; Labialle S; Michaud M; Cogne S; Mazane A; Coleman AW; Rigal D; Baggetto LG
Biochemistry; 2005 Mar; 44(11):4499-509. PubMed ID: 15766280
[TBL] [Abstract][Full Text] [Related]
6. Fluorescent verapamil derivative for monitoring activity of the multidrug transporter.
Lelong IH; Guzikowski AP; Haugland RP; Pastan I; Gottesman MM; Willingham MC
Mol Pharmacol; 1991 Oct; 40(4):490-4. PubMed ID: 1681415
[TBL] [Abstract][Full Text] [Related]
7. In vitro-to-in vivo prediction of P-glycoprotein-based drug interactions at the human and rodent blood-brain barrier.
Hsiao P; Bui T; Ho RJ; Unadkat JD
Drug Metab Dispos; 2008 Mar; 36(3):481-4. PubMed ID: 18057117
[TBL] [Abstract][Full Text] [Related]
8. P-Glycoprotein is localized in intermediate-density membrane microdomains distinct from classical lipid rafts and caveolar domains.
Radeva G; Perabo J; Sharom FJ
FEBS J; 2005 Oct; 272(19):4924-37. PubMed ID: 16176266
[TBL] [Abstract][Full Text] [Related]
9. Haloperidol is an inhibitor but not substrate for MDR1/P-glycoprotein.
Iwaki K; Sakaeda T; Kakumoto M; Nakamura T; Komoto C; Okamura N; Nishiguchi K; Shiraki T; Horinouchi M; Okumura K
J Pharm Pharmacol; 2006 Dec; 58(12):1617-22. PubMed ID: 17331325
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of caveolin-1 increases plasma membrane fluidity and reduces P-glycoprotein function in Hs578T/Dox.
Cai C; Zhu H; Chen J
Biochem Biophys Res Commun; 2004 Jul; 320(3):868-74. PubMed ID: 15240128
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of MDR1 in an intestinal cell line results in increased cholesterol uptake from micelles.
Tessner TG; Stenson WF
Biochem Biophys Res Commun; 2000 Jan; 267(2):565-71. PubMed ID: 10631102
[TBL] [Abstract][Full Text] [Related]
12. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.
Alahari SK; Dean NM; Fisher MH; Delong R; Manoharan M; Tivel KL; Juliano RL
Mol Pharmacol; 1996 Oct; 50(4):808-19. PubMed ID: 8863825
[TBL] [Abstract][Full Text] [Related]
14. Effect of Stemona curtisii root extract on P-glycoprotein and MRP-1 function in multidrug-resistant cancer cells.
Limtrakul P; Siwanon S; Yodkeeree S; Duangrat C
Phytomedicine; 2007 Jun; 14(6):381-9. PubMed ID: 17467965
[TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 and doxorubicin-induced P-glycoprotein modulate plasma cholesterol membrane accessibility in erythrolymphoblastic cell line.
Zhu M; LE Moyec L; Starzec A; Stierle V; Marbeuf-Gueye C
Anticancer Res; 2010 Sep; 30(9):3451-8. PubMed ID: 20944122
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial localization and activity of P-glycoprotein in doxorubicin-resistant K562 cells.
Munteanu E; Verdier M; Grandjean-Forestier F; Stenger C; Jayat-Vignoles C; Huet S; Robert J; Ratinaud MH
Biochem Pharmacol; 2006 Apr; 71(8):1162-74. PubMed ID: 16499877
[TBL] [Abstract][Full Text] [Related]
17. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
[TBL] [Abstract][Full Text] [Related]
18. Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp.
Molnár J; Kars MD; Gündüz U; Engi H; Schumacher U; Van Damme EJ; Peumans WJ; Makovitzky J; Gyémánt N; Molnár P
Acta Histochem; 2009; 111(4):329-33. PubMed ID: 19124148
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol modulates P-glycoprotein activity in human peripheral blood mononuclear cells.
Troost J; Albermann N; Emil Haefeli W; Weiss J
Biochem Biophys Res Commun; 2004 Apr; 316(3):705-11. PubMed ID: 15033457
[TBL] [Abstract][Full Text] [Related]
20. Acridones circumvent P-glycoprotein-associated multidrug resistance (MDR) in cancer cells.
Gopinath VS; Thimmaiah P; Thimmaiah KN
Bioorg Med Chem; 2008 Jan; 16(1):474-87. PubMed ID: 17933543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
